Like baseball scouts trying to pick tomorrow's stars, drug-company scientists like J&J's have become drug hunters who search outside their labs for new medicines for their lineups.
FDA asks Sanofi and Regeneron to conduct an assessment of the potential for a cholesterol drug they are codeveloping to cause neurocognitive adverse events.
Ahead of the Tape: There is no reason Urban Outfitters' stock can't maintain its premium, but others of its peers have fallen out of fashion with surprising speed.
After years of moving in lock step on the back of global economic shocks, individual stocks increasingly have been dancing to their own tune.
As the bull market turns five years old, stock investors have a lot to celebrate. But this bull market is showing its age.
Al Lewis says the former Fed chairman earns $6,000 a minute telling international bankers that he wished average people would only understand why he bailed out ... banks.
A judge ruled against RBC Capital Markets in a suit challenging the bank's advice in the buyout of ambulance operator Rural/Metro, a decision likely to rattle Wall Street and empower shareholders suing over deals.
Five years after the last one ended, we look at how long the typical bear market lasts—and how to prepare for the next one.
U.S. wireless carriers have rejiggered the prices of their service plans again, extending a period of unusual volatility triggered by an aggressive push for customers by T-Mobile US Inc.
Usually, but not always. Here are two exceptions, and a way to help decide.